Medicine and Dentistry
Proton Therapy
100%
Esophageal Cancer
71%
Radiation Therapy
41%
Neoplasm
38%
Chemoradiotherapy
32%
Surgery
30%
Photon Therapy
28%
Head and Neck Cancer
27%
Rectum Cancer
27%
Volumetric Modulated Arc Therapy
24%
Arm
18%
Four Dimensional Computed Tomography
15%
Lung Cancer
15%
Breathing
15%
Volume CT
13%
Adjuvant Chemoradiotherapy
13%
Sarcopenia
13%
Non Small Cell Lung Cancer
13%
Diaphragm
13%
Image-Guided Radiation Therapy
13%
Carotid Artery
13%
Induction Chemotherapy
13%
Neoadjuvant Therapy
13%
Skeletal Muscle
11%
Disease
8%
Malignant Neoplasm
7%
Recurrent Disease
7%
Drug Megadose
7%
Computer Assisted Tomography
7%
Treatment of Non-Small Cell Lung Cancer
6%
Head and Neck Squamous Cell Carcinoma
6%
Overall Survival
6%
Re-Irradiation
6%
Capecitabine
6%
Oxaliplatin
6%
Prognostic Factor
6%
Chronic Obstructive Pulmonary Disease
6%
Logistic Regression Analysis
6%
Keyphrases
Esophageal Cancer
41%
Robustness Evaluation
27%
Intensity-modulated Proton Therapy
27%
Proton Radiotherapy
24%
Volumetric Modulated Arc Therapy
21%
Radiotherapy
21%
Neoadjuvant Chemoradiotherapy (nCRT)
17%
Resection
17%
Target Coverage
16%
Model-based Approach
14%
Replanning
14%
Late Toxicity
13%
Cancer Patients
13%
Sarcopenia
13%
Head-and-neck Cancer
13%
Ischemic Cerebrovascular Events
13%
Photon Radiotherapy
13%
Proton
13%
Locally Recurrent Rectal Cancer
13%
Consensus-based
13%
Delineation Guidelines
13%
Pneumonia
13%
At-risk
12%
Normal Tissue Complication Probability
7%
4DCT
7%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
6%
4D-CBCT
6%
4D Cone-beam Computed Tomography
6%
Computed Tomography
6%
Radiotherapy Techniques
6%
Lung
6%
Re-recurrence
5%
Tumor
5%
Anatomical Changes
5%
Pharmacology, Toxicology and Pharmaceutical Science
Esophagus Cancer
54%
Chemoradiation Therapy
47%
Head and Neck Cancer
27%
Neoplasm
23%
Prospective Cohort Study
13%
Chronic Obstructive Lung Disease
13%
Adjuvant
13%
Sarcopenia
13%
Lung Cancer
13%
Thorax Tumor
13%
Chemotherapy
13%
Rectum Cancer
13%
Oxaliplatin
8%
Capecitabine
8%
Malignant Neoplasm
6%
Small Cell Lung Cancer
6%
Blood Vessel Injury
6%
Head and Neck Squamous Cell Carcinoma
6%
Overall Survival
6%
Fluorouracil
5%
Folinic Acid
5%
Disease
5%
